Fractus Sues ResMed for Patent Infringement Over Wireless Connectivity Technologies
- Fractus has filed a patent infringement lawsuit against ResMed regarding its connected sleep apnea devices.
- The lawsuit claims ResMed violates multiple Fractus patents essential for reliable wireless connectivity in health technology.
- Fractus aims to protect its intellectual property and uphold fair competition within the technology sector against ResMed.
Fractus Takes Legal Action Against ResMed Over Patent Infringement
In a significant legal development, Fractus, a leading innovator in geometry-based antenna technology, files a patent infringement lawsuit against ResMed in the U.S. District Court for the Southern District of California. The case, numbered 3:25-cv-02680-LL-JLB, centers around allegations that ResMed’s connected sleep apnea devices and therapies violate multiple patents held by Fractus. These patents pertain to high-performance, miniaturized multiband antennas, integral for ensuring reliable wireless connectivity in health technology. Fractus CEO Jordi Ilario emphasizes the company's commitment to protecting its intellectual property, which he views as essential for fostering a fair competitive landscape for innovators.
Fractus has invested decades in research and development, resulting in a robust portfolio of over 40 patented inventions that are crucial for the connectivity of various consumer technologies, including smartphones and Internet of Things (IoT) devices. The importance of these technologies has surged, particularly in the healthcare sector, where digital health initiatives and remote patient monitoring are becoming increasingly vital. Ruben Bonet, Executive Chairman of Fractus, underscores the necessity of safeguarding the value of their inventions, which he believes is essential for allowing technology leaders to build on fairly licensed foundations. This legal action reflects Fractus's commitment to ensuring that innovations are respected and that the integrity of the technology sector is maintained.
The legal representation for Fractus is provided by Kobre & Kim LLP, featuring a distinguished team of trial lawyers led by Michael Ng, Daniel Zaheer, and George Stamatopoulos. The team expresses pride in partnering with Fractus to defend its groundbreaking innovations. The lawsuit not only seeks to enforce Fractus's intellectual property rights but also aims to deter unauthorized use of its technologies. This approach is particularly relevant as the demand for reliable connectivity in health technology escalates, highlighting Fractus's role as a pivotal player in the ongoing evolution of digital health solutions.
In addition to its legal pursuits, Fractus has garnered numerous accolades for its contributions to technology, including recognition as a World Economic Forum Technology Pioneer in 2005 and the European Inspiring Company Award from the London Stock Exchange Group in 2017. These honors reflect Fractus's influence and commitment to innovation, further emphasizing the stakes involved in the current litigation against ResMed. As the case unfolds, the implications for both companies and the broader health technology industry could be profound, particularly regarding the protection of intellectual property and the future of wireless connectivity solutions.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

